The total return over the past 12 months is +121.94% vs. +16.94% for the S&P 500. So far it's up +41.09% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | +121.69% | +20.56% | (4.34%) | (39.18%) | (41.33%) | (39.87%) |
| Total Return CAGR | +121.94% | +20.57% | (4.33%) | (39.18%) | (41.33%) | (39.87%) |
| Revenue CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
Achieve Life Sciences, Inc. (ACHV)
| Year | Start price | End price | ACHV Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $4.97 | $7.01 | +41.09% | +14.51% | +26.58% |
| 2025 | $3.52 | $4.97 | +41.25% | +17.72% | +23.53% |
| 2024 | $4.12 | $3.52 | (14.55%) | +24.89% | (39.44%) |
| 2023 | $2.45 | $4.12 | +68.28% | +26.19% | +42.09% |
| 2022 | $7.78 | $2.45 | (68.55%) | (18.17%) | (50.38%) |
| 2021 | $8.10 | $7.78 | (3.96%) | +28.74% | (32.70%) |
| 2020 | $10.60 | $8.10 | (23.57%) | +18.37% | (41.94%) |
| 2019 | $24.20 | $10.60 | (56.19%) | +31.22% | (87.41%) |
| 2018 | $268.00 | $24.20 | (90.97%) | (4.56%) | (86.41%) |
| 2017 | $1,100.00 | $268.00 | (75.64%) | +21.70% | (97.34%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
